Biological age acceleration and cardiovascular–kidney–metabolic syndrome progression: evidence from UK Biobank and NHANES
Abstract Objective: We examined associations of biological age acceleration with cardiovascular–kidney–metabolic (CKM) syndrome progression and baseline stage burden. Methods: Longitudinal analyses included 326,218 UK Biobank participants, and cross-sectional analyses included 5,228 NHANES adults. PhenoAge and KDMAge a...